Difference between revisions of "Alpha synuclein"
| Line 39: | Line 39: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/ | + | | [http://gibk21.bse.kyutech.ac.jp/netasa/asaview/tmp/120866ext.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/netasa/asaview/tmp/120866ext.asa.asa.out ASAView] pdf | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 07:21, 25 July 2007
| Template:Infobox header| Alpha synuclein | |
|---|---|
| Alpha synuclein | |
| Substrate peptide name | Alpha synuclein |
| Synonyms | Non-A beta component of AD amyloid
Non-A4 component of amyloid precursor |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P37840 |
| Reactive glutamines | Q79, Q99 |
| Reactive lysines | K80 |
| Substrate sequence | VTAVAQKTVEGA
FVKKDQLGKNE |
| Structure | 1XQ8 |
| Surface accessibility | ASAView pdf
ASAView pdf |
| Disorder prediction | IUPred |
| Reference | PMID:12576551 |
| Notes | |
| Template:Infobox header | | |
